NCT00801827View on ClinicalTrials.gov

PET Imaging and Bariatric Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2012

Conditions
Obesity, Morbid
Interventions
DRUG

F-18 (fallypride)

Subjects undergoing bariatric surgery will have Positron Emission Tomography (PET)scans of their brains using the radioligand fallypride before and after the operation.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00801827 - PET Imaging and Bariatric Surgery | Biotech Hunter | Biotech Hunter